Vor Biopharma (VOR) Q3 2024 Earnings
VOR·Reported November 7, 2024·Before market open
Diluted EPS came in at $-0.40.
Diluted EPS
$-0.40met estimate
Consensus: $-0.40
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Vor Biopharma's Q3 2024 earnings report.
Vor Biopharma (VOR) reported Q3 2024 earnings on November 7, 2024 before market open.
Vor Biopharma reported diluted EPS of $-0.40 for Q3 2024.
EPS beat the consensus estimate of $-0.40 by $0.00.
You can read the 10-Q periodic report (0000950170-24-123245) directly on SEC EDGAR. The filing index links above go to sec.gov.